Rituximab Use for the Treatment of Childhood Nephrotic Syndrome by Canadian Pediatric Nephrologists: A National Survey.

ABSTRACT:

Background

There is known practice variation in the treatment of frequently relapsing, steroid-dependent, and steroid-resistant nephrotic syndrome in children. Rituximab is an emerging therapy for difficult-to-treat nephrotic syndrome; however, there are no clear treatment guidelines. We therefore hypothesized that a wide variety of approaches to this therapy exist.

Objective

To evaluate when and how rituximab is used for the treatment of childhood nephrotic syndrome in Canada.

Design and setting

An online survey was used.

Participants

Canadian pediatric nephrologists.

Methods

A cross-sectional survey was distributed across Canada through the Canadian Association of Pediatric Nephrologists (CAPN) to evaluate rituximab treatment practices.

Results

SUBMITTER: Meeuwisse C 

PROVIDER: S-EPMC8922210 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature